Q1 Earnings Forecast for ACAD Issued By HC Wainwright
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Free Report) – Investment analysts at HC Wainwright issued their Q1 2025 earnings per share (EPS) estimates for ACADIA Pharmaceuticals in a research note issued on Thursday, February 27th. HC Wainwright analyst A. Fein forecasts that the biopharmaceutical company will post earnings per share of $0.10 for the quarter. HC […]
